These numbers are expected to see substantial growth by 2034. . The market size ... 12 to 17 years with chronic rhinosinusitis with nasal polyps. . In March 2024, Optinose (NASDAQ:OPTN) announced ...

which results in the growth of nasal polyps in the nose that can sometimes require surgical intervention. In severe cases, polyps recur, so patients have to undergo multiple operations.

Medications can shrink nasal polyps. Surgery is often needed to remove them, but they can grow back unless the underlying cause is addressed.

Nose bumps that grow inside your nostrils can be caused by ... Regardless of what you're dealing with inside your nose, ...

The FDA has started its review of Nucala (mepolizumab) for the inflammatory condition, which results in the growth of nasal polyps in the nose that can obstruct airflow and cause mucus discharge ...

Chronic sinusitis can be caused by abnormal growths in the sinuses called nasal polyps, allergies, infections, or other medical conditions. If you've had symptoms for more than 12 weeks ...

Depemokimab is designed in such a way that it targets and suppresses a key inflammatory pathway underlying nasal polyp growth and nasal obstruction. The full results from the ANCHOR-1 and ANCHOR-2 ...